|
1
|
El-Salhy M: Irritable bowel syndrome:
Diagnosis and pathogenesis. World J Gastroenterol. 18:3135–5163.
2012. View Article : Google Scholar
|
|
2
|
El-Salhy M: Recent developments in the
pathophysiology of irritable bowel syndrome. World J Gastroenterol.
21:7621–7636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Irritable bowel syndrome: Diagnosis, pathogenesis and
treatment options. Nova Science Publishers, Inc.; New York:
2012
|
|
4
|
El-Salhy M, Hatlebakk JG, Gilja OH and
Hausken T: Irritable bowel syndrome: Recent developments in
diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol
Hepatol. 8:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Salhy M, Gundersen D, Gilja OH,
Hatlebakk JG and Hausken T: Is irritable bowel syndrome an organic
disorder? World J Gastroenterol. 20:384–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Salhy M, Seim I, Chopin L, Gundersen D,
Hatlebakk JG and Hausken T: Irritable bowel syndrome: The role of
gut neuroendocrine peptides. Front Biosci (Elite Ed). 4:2783–2800.
2012.PubMed/NCBI
|
|
7
|
El-Salhy M and Gilja OH: Abnormalities in
ileal stem, neurogenin 3, and enteroendocrine cells in patients
with irritable bowel syndrome. BMC Gastroenterol. 17:902017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Duodenal chromogranin a cell density as
a biomarker for the diagnosis of irritable bowel syndrome.
Gastroenterol Res Pract. 2014:4628562014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Endocrine cells in the ileum of
patients with irritable bowel syndrome. World J Gastroenterol.
20:2383–2391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Salhy M, Gundersen D, Hatlebakk JG,
Gilja OH and Hausken T: Abnormal rectal endocrine cells in patients
with irritable bowel syndrome. Regul Pept. 188:60–65. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
El-Salhy M, Gundersen D, Ostgaard H,
Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of
serotonin and peptide YY cells in the colon of patients with
irritable bowel syndrome. Dig Dis Sci. 57:873–878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
El-Salhy M, Patcharatrakul T, Hatlebakk
JG, Hausken T, Gilja OH and Gonlachanvit S: Chromogranin A cell
density in the large intestine of Asian and European patients with
irritable bowel syndrome. Scand J Gastroenterol. 52:691–697. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
El-Salhy M, Patcharatrakul T, Hatlebakk
JG, Hausken T, Gilja OH and Gonlachanvit S: Enteroendocrine,
Musashi 1 and neurogenin 3 cells in the large intestine of Thai and
Norwegian patients with irritable bowel syndrome. Scand J
Gastroenterol. 52:1331–1339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dizdar V, Spiller R, Singh G, Hanevik K,
Gilja OH, El-Salhy M and Hausken T: Relative importance of
abnormalities of CCK and 5-HT (serotonin) in Giardia-induced
post-infectious irritable bowel syndrome and functional dyspepsia.
Aliment Pharmacol Ther. 31:883–891. 2010.PubMed/NCBI
|
|
15
|
El-Salhy M, Vaali K, Dizdar V and Hausken
T: Abnormal small-intestinal endocrine cells in patients with
irritable bowel syndrome. Dig Dis Sci. 55:3508–3513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
El-Salhy M, Hatlebakk JG and Hausken T:
Reduction in duodenal endocrine cells in irritable bowel syndrome
is associated with stem cell abnormalities. World J Gastroenterol.
21:9577–9587. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Montgomery RK and Breault DT: Small
intestinal stem cell markers. J Anat. 213:52–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kayahara T, Sawada M, Takaishi S, Fukui H,
Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H and Chiba
T: Candidate markers for stem and early progenitor cells, Musashi-1
and Hes1, are expressed in crypt base columnar cells of mouse small
intestine. FEBS Lett. 535:131–135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Potten CS: Stem cells in gastrointestinal
epithelium: Numbers, characteristics and death. Philos Trans R Soc
Lond B Biol Sci. 353:821–830. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barker N, van Oudenaarden A and Clevers H:
Identifying the stem cell of the intestinal crypt: Strategies and
pitfalls. Cell Stem Cell. 11:452–460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Potten CS, Booth C and Pritchard DM: The
intestinal epithelial stem cell: The mucosal governor. Int J Exp
Pathol. 78:219–243. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee CS, Perreault N, Brestelli JE and
Kaestner KH: Neurogenin 3 is essential for the proper specification
of gastric enteroendocrine cells and the maintenance of gastric
epithelial cell identity. Genes Dev. 16:1488–1497. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee CS and Kaestner KH: Clinical
endocrinology and metabolism. Development of gut endocrine cells.
Best Pract Res Clin Endocrinol Metab. 18:453–462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
El-Salhy M, Mazzawi T, Gundersen D and
Hausken T: Chromogranin A cell density in the rectum of patients
with irritable bowel syndrome. Mol Med Rep. 6:1223–1225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
El-Salhy M, Wendelbo I and Gundersen D:
Reduced chromogranin A cell density in the ileum of patients with
irritable bowel syndrome. Mol Med Rep. 7:1241–1244. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El-Salhy M, Wendelbo I and Gundersen D:
Serotonin and serotonin transporter in the rectum of patients with
irritable bowel disease. Mol Med Rep. 8:451–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El-Salhy M: Possible role of intestinal
stem cells in the pathophysiology of irritable bowel syndrome.
World J Gastroenterol. 26:1427–1438. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
El-Salhy M, Gilja OH, Gundersen D and
Hausken T: Endocrine cells in the oxyntic mucosa of the stomach in
patients with irritable bowel syndrome. World J Gastrointest
Endosc. 6:176–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
El-Salhy M, Gilja OH and Hausken T:
Chromogranin A cells in the stomachs of patients with sporadic
irritable bowel syndrome. Mol Med Rep. 10:1753–1757. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
El-Salhy M, Gilja OH, Hatlebakk JG and
Hausken T: Stomach antral endocrine cells in patients with
irritable bowel syndrome. Int J Mol Med. 34:967–974. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
El-Salhy M, Gilja OH and Hatlebakk JG:
Overlapping of irritable bowel syndrome with erosive esophagitis
and the performance of Rome criteria in diagnosing IBS in a
clinical setting. Mol Med Rep. 20:787–794. 2019.PubMed/NCBI
|
|
32
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han ME and Oh SO: Gastric stem cells and
gastric cancer stem cells. Anat Cell Biol. 46:8–18. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khurana S and Mills JC: The gastric mucosa
development and differentiation. Prog Mol Biol Transl Sci.
96:93–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Akasaka Y, Saikawa Y, Fujita K, Kubota T,
Ishikawa Y, Fujimoto A, Ishii T, Okano H and Kitajima M: Expression
of a candidate marker for progenitor cells, Musashi-1, in the
proliferative regions of human antrum and its decreased expression
in intestinal metaplasia. Histopathology. 47:348–356. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Murata H, Tsuji S, Tsujii M, Nakamura T,
Fu HY, Eguchi H, Asahi K, Okano H, Kawano S and Hayashi N:
Helicobacter pylori infection induces candidate stem cell
marker Musashi-1 in the human gastric epithelium. Dig Dis Sci.
53:363–369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
El-Salhy M, Hausken T, Gilja OH and
Hatlebakk JG: The possible role of gastrointestinal endocrine cells
in the pathophysiology of irritable bowel syndrome. Expert Rev
Gastroenterol Hepatol. 11:139–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Habib AM, Richards P, Rogers GJ, Reimann F
and Gribble FM: Co-localisation and secretion of glucagon-like
peptide 1 and peptide YY from primary cultured human L cells.
Diabetologia. 56:1413–1416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
El-Salhy M, Hatlebakk JG and Hausken T:
Possible role of peptide YY (PYY) in the pathophysiology of
irritable bowel syndrome (IBS). Neuropeptides. 79:1019732020.
View Article : Google Scholar : PubMed/NCBI
|
